期刊文献+

CD45单抗及188Re-亲和素二步法预定位对淋巴瘤Raji细胞的放射免疫效应研究

Effect of the two-step pretargeting radioimmunotherapy of CD45 monoclonal antibody and 188Re-Avidin on lymphoma Raji cell line
原文传递
导出
摘要 目的 探讨CD45单抗及188Re-亲和素(Avidin)二步法预定位对人淋巴瘤Raji细胞的放射免疫效应.方法 188Re对CD45单抗及Avidin的标记采用直接标记法,采用纸层析法测定标记率及放化纯度.分析188Re-CD45单抗与Raji细胞的体外结合能力,并进行体外竞争结合实验,采用CCK-8法测定二步法预定位组、188Re-CD45单抗组、188Re-Avidin组和188ReO4-组对Raji细胞的增殖抑制效应,计算Raji细胞存活率和抑制率.结果 188Re-CD45单抗与Raji细胞的特异性结合率为(70.92±1.91)%,同时加入188Re-CD45单抗和过量的CD45单抗,则细胞结合率平均为(7.96±0.87)%.二步法预定位组、188 Re-CD45单抗组、1888Re-Avidin组和1888ReO4-组对Raji细胞的增殖均有抑制作用,抑制率与放射性活度呈正相关(r=0.907 ~0.992,P<0.05);在相同放射性活度下,二步法预定位组在各时间点的抑制作用均高于188 Re-CD45单抗组、188Re-Avidin组和188 ReO4-组(t=124.76 ~ 607.98,P<0.05).结论 188 Re-CD45单抗可特异性地与Raji细胞结合,CD45单抗及188 Re-Avidin二步法预定位对人淋巴瘤Raji细胞具有明显的抑制作用. Objective To study the effect of two-step pretargeting radioimmunotherapy of CD45 McAb and 188Re-Avidin on lymphoma Raji cell line.Methods The CD45 McAb and Avidin were directly labeled with 188Re,and the labeling efficiency and radiochemical purity were measured by the paper chromatography.The specific binding test and competition binding test between 188 Re-CD45 McAb and Raji cells in vitro were also performed.CCK-8 assay was used to determine the inhibition effect on Raji cell proliferation in the pretargeted group,188Re-CD45 McAb,188Re-Avidin and 188ReO4 groups,then the cell survival and proliferation inhibition rate were calculated.Results The specific cell binding rate of 188Re-CD45 McAb with Raji cells was (70.92 ± 1.91) %,in the competition group,the binging rate of 188Re-CD45 McAb with Raji cells was only (7.96 ± 0.87)%.The Raji cells proliferation was inhibited in all groups with 188Re radiolabel,and the inhibition rate was positively correlated with the radioactivity dose (r=0.907-0.992,P 〈0.05).However,at the same dose,the inhibition effect in the group of two-step pretargeting at each time point were all stronger than those of 188Re-CD45 McAb,188Re-Avidin and 188 ReO4-alone (t =124.76-607.98,P 〈 0.05).But there was no significantly statistical difference in the inhibitory effect between the groups of 188Re-Avidin and 188ReO4-(P 〉 0.05).Conclusions It is confirmed that 188Re-CD45 McAb could be specifically bound to Raji cells,and the two-step pretargeting of CD45 McAb and 188Re-Avidin has obvious inhibitory effect on the Raji cell proliferation.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2015年第8期566-569,574,共5页 Chinese Journal of Radiological Medicine and Protection
基金 广东省自然科学基金($2013010014420) 广东省科技计划项目(20128031800391)
关键词 预定位 亲和素 188Re CD45单抗 Raji细胞系 Pretargeting technique Avidin 188Re CD45 McAb Raji cell line
  • 相关文献

参考文献17

  • 1Ratei R, Sperling C, Karawajew L, et al. Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute |ymphoblastic leukemia [ J ]. Ann Hematol, 1998, 77(3): 107-114.
  • 2郑文莉,李贵平.亲和素-生物素系统预定位放免治疗白血病的研究[J].放射免疫学杂志,2013,26(4):428-432. 被引量:2
  • 3汪兵,李贵平.放射性核素标记单克隆抗体靶向治疗血液系统恶性肿瘤[J].放射免疫学杂志,2011,24(2):144-147. 被引量:2
  • 4李贵平,汪兵,黄宝丹,杜丽,池晓华,黄凯,张辉,郑文莉.CD45单抗介导的淋巴瘤荷瘤裸鼠三步法预定位放免显像[J].中山大学学报(医学科学版),2014,35(1):127-131. 被引量:2
  • 5郑文莉,李贵平,黄宝丹,杜丽,黄凯.^(188)Re直接法标记CD45单抗及其体内生物分布研究[J].中华临床医师杂志(电子版),2013,7(18):135-138. 被引量:4
  • 6Pagel JM, Matthews DC, Kenoyer A, et al. Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia[ J]. Cancer Res, 2009, 69 ( 1 ) : 185-192.
  • 7Iznaga-Escobar N, Ramirez IL, Izquierdo JC, et al. 8SRe- labeled anti-epidermal growth factor receptor humanized monoclonal antihody h-R3 : labeling conditions, Or vitro and in vivo stability[J]. Methods Find Exp Clin Pharmacol, 2003, 25 (9) : 703-711.
  • 8Luo TY, Cheng PC, Chiang PF, et al. mRe-HYNIC- trastuzumab enhances the effect of apoptosis induced by trastuzumab in HER2-overexpressing breast cancer cells[J]. Ann Nucl Med, 2015, 29(1):52-62.
  • 9Pillai MR, Dash A, Knapp FF Jr. Rhenium-188: availability from the lSSw/lSSRe generator and status of current applications [J]. Curr Radiopharm, 2012, 5(3): 228-243.
  • 10Liitje S, Rijpkema M, Goldenberg DM, et al. Pretargeted dual- modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer [ J ]. Cancer Res, 2014, 74(21 ) :6216-6223.

二级参考文献85

  • 1孙建中,朱承谟,管樑,李彪,张冀先,史爱兰,张素胤.生物素-亲和素预定位技术在抗CEA单抗放免显像中的实验研究[J].中华核医学杂志,1996,16(2):81-84. 被引量:3
  • 2Gui-Ping Li,Hui Zhang,Cheng-Mo Zhu,,Jian Zhang,Xu-Feng Jiang.Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma[J].World Journal of Gastroenterology,2005,11(40):6288-6294. 被引量:5
  • 3夏忠军,王风华,黄慧强,骆卉妍,李宇红,林桐榆,姜文奇,管忠震.含美罗华方案治疗B细胞性惰性淋巴瘤34例报告[J].癌症,2006,25(4):490-494. 被引量:9
  • 4Kohler G,Milsteln C.Continuous cultures of fused cells secreting antibody of predefined apecifieily[J].J Immunol,2005,174(5):2453.
  • 5Mellstedt H.Monoclonal antibodies in human cancer[J].Drugs Today (Barc),2003,39 Supple C:1-16.
  • 6Feuqier P,van Hoof A,Sebban C,et al.Long-term results of the R-CHOP study of elderly patients with diffuse large B-cell lymphoma:A study by the Group Etude des lymphoma de LAdute[J].J Clin Oncol,2005,18(23):4117-4126.
  • 7Vose JM,Link BK,Gross BML,et al.Phase Ⅱ study of rituximab in combination with CHOP chemotherapy in patients with previously untreated,aggressive non-Hodgkin's lymphoma[J].J Clin Oncol,2001,19(2):389-397.
  • 8Lundin A,Porwit-MacDonald E,Rossmann D,et al.Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody,CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia[J].Leukema,2004,18(3):484-490.
  • 9Knapp FF.Rhenium-188-a generator-derived radioisotope for cancer therapy[J].Cancer Biother Radiopharm,1998,13(5):337-349.
  • 10Wagner HN,Wiseman GA,Marm MCS,et al.Administration guidelines for radioimmunotherapy of non-Hodgldn's lymphoma with90Y-labelled anti-CD20 monoclonal antibody[J].J Nucl Med,2002,43(2):267-272.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部